Ivor MacLeod
Director of Finance/CFO bei SCYNEXIS, INC.
Vermögen: 235 506 $ am 31.03.2024
Profil
Ivor MacLeod is currently the Chief Financial & Accounting Officer at SCYNEXIS, Inc. Prior to this, he held positions as Vice President-Finance at Merck & Co., Inc., Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc., and Chief Financial & Compliance Officer, SVP at Eisai, Inc. From 2021 to 2022, he served as the Chief Financial & Accounting Officer at Athersys, Inc. Mr. MacLeod completed his undergraduate degree at the University of St. Andrews and holds an MBA from Eller College of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SCYNEXIS, INC.
0,43% | 26.01.2024 | 160 185 ( 0,43% ) | 235 472 $ | 31.03.2024 |
ATHERSYS, INC.
0,01% | 14.08.2023 | 5 732 ( 0,01% ) | 34 $ | 31.03.2024 |
Aktive Positionen von Ivor MacLeod
| Unternehmen | Position | Beginn |
|---|---|---|
| SCYNEXIS, INC. | Director of Finance/CFO | 24.10.2022 |
Ehemalige bekannte Positionen von Ivor MacLeod
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Director of Finance/CFO | 30.06.2022 |
| MERCK & CO., INC. | Director of Finance/CFO | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Director of Finance/CFO | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director of Finance/CFO | - |
Ausbildung von Ivor MacLeod
| University of St. Andrews | Undergraduate Degree |
| Eller College of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
